DNTH logo

Dianthus Therapeutics Inc

DNTH

$25.48

+ $6.42 (35.63%) This month

Closed: 23 Feb 2024 21:00 US/Eastern

Key details

CEO

Jason Gardner

Employees

81

Headquarters

Cambridge, US

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

About Dianthus Therapeutics Inc

magenta therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. by creating a platform focused on key areas of transplant medicine, magenta therapeutics is pioneering an integrated, but modular approach to stem cell therapies that reboot the blood and immune systems to create patient benefit. founded by internationally recognized leaders in stem cell transplant medicine, magenta therapeutics was launched in 2016 by third rock ventures and atlas venture and is headquartered in cambridge, mass. for more information, please visit www.magentatx.com.

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
Finimize
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG